This is a prospective, randomized, double blinded, multi-center, parallel arm, non-inferiority, pivotal clinical trial to demonstrate that the safety and efficacy of a new transducer which delivers two simultaneous lines of treatment at the same treatment depth is not inferior to a standard transducer to improve jawline definition and submental skin laxity.